clinical evidence bpc-157 safety vs. TB-500: What Patients Should Know BPC-157: Experimental Peptide Creates Risk
Description
2005 Sep 2;77(16):2051-8
[DOI] [PubMed] [Google Scholar] 57.Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P
Understanding the shared molecule but distinct indications helps prevent confusion, particularly when patients transition between providers or therapies
[Effect of mecobalamin on diabetic neuropathies
Research-grade solution for peptide reconstitution and dilution
The risks of folic acid to the nervous system in vitamin B12 deficiency: rediscovered in the era of folic acid fortification policies
